Gaudium IVF and Women Health Share Price Target 2026 Analyst Forecast Bull and Bear Case

The Gaudium IVF and Women Health share price target 2026 is Rs 125, based on analyst estimates and the FY27 earnings recovery thesis for Gaudium IVF and Women Health (NSE: GAUDIUMIVF). Q4 FY26 results announced are the immediate re-rating trigger. This article covers the complete Gaudium IVF and Women Health share price target analysis including sector tailwinds, peer context, key risks, and bull and bear case scenarios.

Click Here – Get Free Investment Predictions

Gaudium IVF and Women Health Share Price Target 2026: Key Takeaways

• Gaudium IVF and Women Health share price target 2026: Rs 125 (base case, 20% upside from CMP Rs 103.2)
• Bull case: Rs 150 | Bear case: Rs 82.6
• NSE ticker: GAUDIUMIVF | Sector: IVF Clinics and Women Healthcare | Market cap: Rs 206 crore
• 52 week range: Rs 62 to Rs 175 | PE: sector-average
• Key catalyst: Q4 FY26 results confirming FY27 earnings recovery
• Key risk: FY27 earnings miss or sustained FII outflows from Indian equities

Gaudium IVF and Women Health Company Overview

Gaudium IVF and Women Health (NSE: GAUDIUMIVF) is a recently listed IVF and women’s healthcare chain operating fertility centres and gynaecology clinics across India, with growing demand for assisted reproductive technology services. At CMP Rs 103.2 against a 52 week range of Rs 62 to Rs 175, the stock trades at a discount to its 52 week high. Market capitalisation is Rs 206 crore with trailing PE of sector-average. Compared to peers in healthcare like Indira IVF and Nova IVF, Gaudium IVF and Women Health is positioned as a potential re-rating candidate toward the Gaudium IVF and Women Health share price target of Rs 125.

Parameter	Value
NSE Ticker	GAUDIUMIVF
Sector	IVF Clinics and Women Healthcare
CMP	Rs 103.2
52 Week High	Rs 175
52 Week Low	Rs 62
Market Cap	Rs 206 crore
Trailing PE	sector-average
12-Month Analyst Target	Rs 125
Bull Case Target	Rs 150
Bear Case Target	Rs 82.6

Why Is the Gaudium IVF and Women Health Share Price Target Set at Rs 125 for 2026

FY27 Earnings Delivery and Revenue Acceleration

The Gaudium IVF and Women Health share price target 2026 of Rs 125 rests on analyst projections of 15 to 20 percent PAT growth in FY27. Q4 FY26 results confirming the earnings recovery trajectory are the most direct catalyst for re-rating from CMP Rs 103.2 toward Rs 125.

Structural Sector Tailwinds in IVF Clinics and Women Healthcare

The IVF Clinics and Women Healthcare sector is expanding on the back of India’s domestic demand growth, PLI scheme support, and rising investment. Gaudium IVF and Women Health’s position among peers in healthcare like Indira IVF and Nova IVF creates a structural growth runway supporting the Gaudium IVF and Women Health share price target of Rs 125 and bull case of Rs 150.

RBI Rate Cut Cycle and Lower Cost of Capital

India’s RBI rate cut cycle, commencing early 2026, reduces Gaudium IVF and Women Health’s borrowing costs and stimulates demand. Lower interest costs improve EPS trajectory, directly supporting the Gaudium IVF and Women Health share price target of Rs 125.

Union Budget 2026-27 Policy Support

Budget 2026-27’s Rs 11.21 lakh crore infrastructure capex and PLI scheme continuity create a positive policy backdrop for Gaudium IVF and Women Health’s IVF Clinics and Women Healthcare operations, improving the probability of achieving the Gaudium IVF and Women Health share price target of Rs 125.

Improving FII Flows Post the April 2026 Tariff Shock

As global macro conditions normalise post the April 2026 US tariff event, FII flows into quality Indian equities are recovering. At sector-average PE, Gaudium IVF and Women Health is positioned as a beneficiary of institutional reallocation toward the Gaudium IVF and Women Health share price target of Rs 125.

Gaudium IVF and Women Health Share Price Targets: Short Term, 12 Month, and Long Term

Short Term Gaudium IVF and Women Health Share Price Target: 3 to 6 Months

The near-term Gaudium IVF and Women Health share price target is anchored to support near the 52 week low of Rs 62. A confirmed Q4 FY26 earnings recovery is the trigger for an initial 10 to 15 percent re-rating toward Rs 125.

12-Month Gaudium IVF and Women Health Share Price Target 2026

The 12-month Gaudium IVF and Women Health share price target 2026 is Rs 125, implying approximately 20 percent upside from CMP Rs 103.2. Track live on NSE ticker GAUDIUMIVF.

Long Term Gaudium IVF and Women Health Share Price Target: FY27 to FY28

For investors with a 2 to 3 year horizon, the long-term Gaudium IVF and Women Health share price target is Rs 150 in the bull case, assuming full earnings delivery and sector re-rating among peers in healthcare like Indira IVF and Nova IVF.

Bull Case and Bear Case for the Gaudium IVF and Women Health Share Price Target

Bull Case Gaudium IVF and Women Health Share Price Target: Rs 150

The bull case of Rs 150 materialises when FY27 earnings beat estimates, IVF Clinics and Women Healthcare tailwinds accelerate, and FII flows return strongly to Indian equities, enabling re-rating toward higher peer multiples.

Bear Case Gaudium IVF and Women Health Share Price Target: Rs 82.6

The bear case of Rs 82.6 materialises if FY27 earnings disappoint and FII outflows persist, with the stock approaching the 52 week low of Rs 62.

Scenario	Target	Key Conditions
Bull Case	Rs 150	FY27 earnings beat, re-rating, FII inflows
Base Case	Rs 125	In-line FY27 delivery, partial FII recovery
Bear Case	Rs 82.6	FY27 miss, guidance cut, FII outflows

Key Risks to the Gaudium IVF and Women Health Share Price Target 2026

US Tariff and Global Macro Risk

Prolonged US tariff tension or a global demand slowdown remains a key macro risk to the Gaudium IVF and Women Health share price target 2026 of Rs 125.

Valuation and Earnings Miss Risk

Any FY27 earnings miss or guidance cut could compress multiples, posing the most direct risk to the Gaudium IVF and Women Health share price target of Rs 125.

Competitive Pressure in IVF Clinics and Women Healthcare

Intensifying competition among peers in healthcare like Indira IVF and Nova IVF could compress Gaudium IVF and Women Health’s pricing power, which must be factored into any assessment of the Gaudium IVF and Women Health share price target of Rs 125.

FII Selling Pressure and Liquidity Risk

Sustained FII outflows from Indian equities can delay re-rating toward the Gaudium IVF and Women Health share price target of Rs 125 regardless of company-level improvement through FY27.

How to Invest in Gaudium IVF and Women Health

Check the Univest Screener for live data

Begin by reviewing Gaudium IVF and Women Health’s Q4 FY26 results, annual report, and FY27 guidance before forming a view on the Gaudium IVF and Women Health share price target of Rs 125. Focus on revenue growth, margin trends, and management commentary on IVF Clinics and Women Healthcare sector opportunities.

Open a Demat and trading account with a SEBI registered stockbroker to buy Gaudium IVF and Women Health (NSE: GAUDIUMIVF) with full regulatory protection. Understand the competitive dynamics among peers in healthcare like Indira IVF and Nova IVF before executing any position.

Plan your entry near the 52 week low support of Rs 62. A confirmed Q4 FY26 earnings uptick and positive FY27 guidance would strengthen the entry case for the Gaudium IVF and Women Health share price target of Rs 125. Set a disciplined stop loss below the 52 week low.

Restrict any single stock to 3 to 5 percent of your total equity portfolio to manage concentration risk, especially in the IVF Clinics and Women Healthcare space where sectoral cycles can amplify volatility.

Always consult a SEBI registered financial advisor before investing based on any Gaudium IVF and Women Health share price target estimate. SEBI Registration No. INH000013776.

Download the Univest iOS App or the Univest Android App to track Gaudium IVF and Women Health’s live price and get daily stock recommendations.

FAQs on Gaudium IVF and Women Health Share Price Target 2026

What is the Gaudium IVF and Women Health share price target for 2026?

Ans. The Gaudium IVF and Women Health share price target 2026 is Rs 125, implying approximately 20 percent upside from CMP Rs 103.2. Bull case is Rs 150 and bear case is Rs 82.6.

What is the Gaudium IVF and Women Health share price target for 2025?

Ans. The Gaudium IVF and Women Health share price target for 2025 was based on FY26 earnings projections. The current 2026 analyst target is Rs 125, reflecting FY27 growth potential from CMP Rs 103.2.

Is Gaudium IVF and Women Health a good buy at Rs 103.2?

Ans. At Rs 103.2, Gaudium IVF and Women Health offers potential upside to the share price target of Rs 125 if FY27 earnings recover. Consult a SEBI registered financial advisor before investing.

What is the 52 week high and low of Gaudium IVF and Women Health?

Ans. The 52 week high of Gaudium IVF and Women Health is Rs 175 and the 52 week low is Rs 62. At CMP Rs 103.2, the stock offers upside potential toward the 12-month share price target of Rs 125.

What are the key risks to the Gaudium IVF and Women Health share price target?

Ans. Key risks to the Gaudium IVF and Women Health share price target of Rs 125 include FY27 earnings miss, US tariff-driven FII outflows, competitive pressure among peers in healthcare like Indira IVF and Nova IVF, and global demand slowdown.

What are the catalysts for the Gaudium IVF and Women Health share price target?

Ans. Primary catalysts include FY27 PAT recovery, IVF Clinics and Women Healthcare sector tailwinds, RBI rate cut support, Union Budget 2026-27 policy uplift, and FII flow normalisation into Indian equities.

How does Gaudium IVF and Women Health compare to its peers?

Ans. Gaudium IVF and Women Health operates in IVF Clinics and Women Healthcare alongside peers in healthcare like Indira IVF and Nova IVF. At CMP Rs 103.2 with market cap Rs 206 crore, the company is positioned as a potential re-rating candidate toward the share price target of Rs 125 on FY27 delivery.

What is the Gaudium IVF and Women Health share price target for 2027?

Ans. The long-term Gaudium IVF and Women Health share price target for FY27 to FY28 is Rs 150 in the bull case, assuming continued earnings growth, sector re-rating, and sustained FII inflows. Consult a SEBI registered financial advisor for personalised guidance.